Related Experiment Video
Updated: May 15, 2026

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study
P Makrythanasis1, B W van Bon, M Steehouwer
1Departement of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Clinical Genetics
|January 17, 2013
Summary
Pathogenic MLL2 gene mutations are the primary cause of Kabuki syndrome (KS). Patients with MLL2 mutations showed more severe symptoms and distinct facial features compared to those without mutations.
Area of Science:
- Genetics
- Developmental Biology
- Clinical Medicine
Background:
- Kabuki syndrome (KS) is a rare congenital disorder.
- Pathogenic variants in the MLL2 gene are the most frequent cause of KS.
- Understanding genotype-phenotype correlations is crucial for KS diagnosis and management.
Purpose of the Study:
- To investigate the genotype-phenotype correlation in a large cohort of Kabuki syndrome patients.
- To identify and characterize MLL2 gene mutations in clinically diagnosed KS patients.
- To correlate MLL2 mutation status with clinical severity and specific phenotypic features.
Main Methods:
- A cohort of 86 clinically defined Kabuki syndrome patients was studied.
- Patients were assessed using a standardized phenotype list and a novel clinical scoring system (MLL2-Kabuki score).
- Full coding region and intron-exon boundaries of the MLL2 gene were sequenced.
Main Results:
- Likely pathogenic MLL2 mutations were identified in 52% (45/86) of patients, including 31 nonsense, 10 missense, and 4 splice-site mutations.
- Patients with pathogenic MLL2 mutations exhibited significantly higher MLL2-Kabuki scores (median 6) compared to those without mutations (median 5).
- Specific facial features, including dysplastic ears, arched eyebrows, blue sclerae, and characteristic lip and nose shapes, were more prevalent in mutation-positive patients.
Conclusions:
- Pathogenic MLL2 mutations are confirmed as the predominant cause of Kabuki syndrome.
- MLL2 mutation status significantly correlates with clinical severity and specific facial dysmorphisms in KS.
- These findings enhance the understanding of MLL2's role in KS and aid in genotype-based clinical assessment.

